Nikhil Pande

791 total citations
30 papers, 227 citations indexed

About

Nikhil Pande is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nikhil Pande has authored 30 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 8 papers in Surgery. Recurrent topics in Nikhil Pande's work include Lung Cancer Treatments and Mutations (12 papers), Head and Neck Cancer Studies (8 papers) and Lung Cancer Research Studies (6 papers). Nikhil Pande is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Head and Neck Cancer Studies (8 papers) and Lung Cancer Research Studies (6 papers). Nikhil Pande collaborates with scholars based in India and United States. Nikhil Pande's co-authors include Kumar Prabhash, Anant Ramaswamy, Amit Joshi, Vijay Patil, Vanita Noronha, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Atanu Bhattacharjee and Vikas Ostwal and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Oncotarget.

In The Last Decade

Nikhil Pande

27 papers receiving 217 citations

Peers

Nikhil Pande

ONCOL

PRM

SURGE

OTORH

Denis Braun France

Reina Sekiya Japan

Pei Jye Voon Malaysia

Lu-Jun Shen China

Gianmarco Leone Italy

Tatiana Hadjieva Bulgaria

Shirley Mo United States

Christopher D’Avella United States

Audrey Lardy-Cléaud France

Christian Sire France

Denis Braun France

Nikhil Pande

157 ×1.2

ONCOL

213 ×1.6

PRM

29 ×0.5

SURGE

16 ×0.3

OTORH

52 ×1.6

Citations per year, relative to Nikhil Pande Nikhil Pande (= 1×) peers Denis Braun

Countries citing papers authored by Nikhil Pande

Since Specialization

Citations

This map shows the geographic impact of Nikhil Pande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Pande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Pande more than expected).

Fields of papers citing papers by Nikhil Pande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Pande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Pande. The network helps show where Nikhil Pande may publish in the future.

Co-authorship network of co-authors of Nikhil Pande

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Pande. A scholar is included among the top collaborators of Nikhil Pande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Pande. Nikhil Pande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patil, Vijay, Nandini Menon, Abhishek Chatterjee, et al.. (2022). Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. EClinicalMedicine. 49. 101449–101449. 13 indexed citations

Joshi, Amit, Nikhil Pande, Vanita Noronha, et al.. (2019). ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes. ecancermedicalscience. 13. 900–900. 24 indexed citations

Ramaswamy, Anant, Vikas Ostwal, Nikhil Pande, et al.. (2019). Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study. South Asian Journal of Cancer. 8(1). 22–26. 4 indexed citations

Prabhash, Kumar, Vijay Patil, Vanita Noronha, et al.. (2019). Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer. Cancer Research Statistics and Treatment. 2(1). 21–21. 2 indexed citations

Ramaswamy, Anant, et al.. (2018). Resection of Isolated Port Site Metastasis in Gall Bladder Cancers—Careful Selection and Perioperative Systemic Therapy May Improve Outcomes. Indian Journal of Surgical Oncology. 9(3). 427–431. 5 indexed citations

Ostwal, Vikas, Nikhil Pande, Reena Engineer, et al.. (2018). Low prevalence of deficient mismatch repair (dMMR) protein in locally advanced rectal cancers (LARC) and treatment outcomes. Journal of Gastrointestinal Oncology. 10(1). 19–29. 11 indexed citations

Patil, Vijay, Raees Tonse, Jayita Deodhar, et al.. (2018). A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies. Neuro-Oncology Practice. 6(4). 305–310. 1 indexed citations

Patil, Vijay, Nikhil Pande, Arun Chandrasekharan, et al.. (2018). Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy. CNS Oncology. 7(2). CNS14–CNS14. 8 indexed citations

Patil, Vijay, Amit Joshi, Vanita Noronha, et al.. (2017). Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of Cabazitaxel versus docetaxel in recurrent Head and Neck Cancer. Annals of Oncology. 28. x100–x100. 1 indexed citations

10.

Patil, Vijay, Vanita Noronha, Amit Joshi, et al.. (2017). Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma. ESMO Open. 2(1). e000168–e000168. 56 indexed citations

11.

Ostwal, Vikas, Anant Ramaswamy, Reena Engineer, et al.. (2017). Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon. Indian Journal of Cancer. 54(3). 530–530. 2 indexed citations

12.

Patil, Vijay, Amit Joshi, Abhishek Mahajan, et al.. (2017). P3.02b-094 Rebiopsy Post Progression in EGFR Mutated Lung Cancer. Journal of Thoracic Oncology. 12(1). S1248–S1249. 3 indexed citations

13.

Talreja, Vikas, Vanita Noronha, Vijay Patil, et al.. (2017). P3.02b-055 Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC. Journal of Thoracic Oncology. 12(1). S1223–S1223. 1 indexed citations

14.

Patil, Vijay, Vanita Noronha, Amit Joshi, et al.. (2017). Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer. Indian Journal of Cancer. 54(1). 25–29. 10 indexed citations

15.

Joshi, Amit, Vijay Patil, Vanita Noronha, et al.. (2017). Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer. Oral Oncology. 75. 54–60. 9 indexed citations

16.

Noronha, Vanita, Vijay Patil, Amit Joshi, et al.. (2017). Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy. ecancermedicalscience. 11. 776–776. 2 indexed citations

17.

Tonse, Raees, Abhijeeth Chandrasekaran, Nikhil Pande, et al.. (2017). Rechallenge temozolomide in glioma: A case series from India. Indian Journal of Cancer. 54(1). 368–371. 2 indexed citations

18.

Noronha, Vanita, Amit Joshi, Vijay Patil, et al.. (2017). Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.. Journal of Clinical Oncology. 35(15_suppl). 6007–6007. 17 indexed citations

19.

Ramaswamy, Anant, Vikas Ostwal, Nikhil Pande, et al.. (2016). Second-Line Palliative Chemotherapy in Advanced Gall Bladder Cancer, CAP-IRI: Safe and Effective Option. Journal of Gastrointestinal Cancer. 47(3). 305–312. 16 indexed citations

20.

Ramaswamy, Anant, et al.. (2016). Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumors: feasible and efficacious. Journal of Gastrointestinal Oncology. 7(4). 638–643. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact